Today
Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results
a few seconds ago
Inspire Medical Systems, Inc.Business Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance
a few seconds ago
Cps Technologies Corp.Business CPS Technologies Corp. Announces Hiring of New Chief Financial Officer
a few seconds ago
Duolingo Reports First Quarter 2026 Results
a minute ago
Biodesix Announces First Quarter 2026 Results and Highlights
a minute ago
Cps Technologies Corp.Business CPS Technologies Announces First Quarter 2026 Financial Results
a minute ago
Praxis Precision Medicines, Inc.Business Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
a minute ago
Fibrobiologics, Inc.Business FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
a minute ago
Senseonics Holdings, Inc.Business Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
a minute ago
Diamondback Energy, Inc.Business Diamondback Energy, Inc. Announces First Quarter 2026 Financial and Operating Results; Increases Base Dividend and Production Guidance
2 minutes ago
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
2 minutes ago
Dorman Products, Inc.Business Dorman Products, Inc. Reports First Quarter 2026 Results and Reaffirms 2026 Guidance
2 minutes ago
Meridian CorporationBusiness Meridian Corporation Reports Revised First Quarter 2026 Results
2 minutes ago
Paramount Skydance CorporationBusiness PARAMOUNT REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
2 minutes ago
Viper Energy, Inc.Business Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Reports First Quarter 2026 Financial and Operating Results
2 minutes ago
Cytokinetics, IncorporatedBusiness Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026
3 minutes ago
Visionary Holdings Inc.Business Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees
3 minutes ago
[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
36 minutes ago
Roadzen Announces Pricing of $8 Million Registered Direct Offering of Ordinary Shares
36 minutes ago
Morgan Stanley Investment Management Introduces Wealth Education Center
an hour ago